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Abstract: Historically, only few chemicals have been identified as neurodevelopmental 
toxicants, however, concern remains, and has recently increased, based upon the 
association between chemical exposures and increased developmental disorders. 
Diminution in motor speed and latency has been reported in preschool children from 
agricultural communities. Organophosphorus compounds (OPs) are pesticides due to their 
acute insecticidal effects mediated by the inhibition of acetylcholinesterase, although other 
esterases as neuropathy target esterase (NTE) can also be inhibited. Other neurological and 
neurodevelopmental toxic effects with unknown targets have been reported after chronic 
exposure to OPs in vivo. We studied the initial stages of retinoic acid acid-triggered 
differentiation of pluripotent cells towards neural progenitors derived from human 
embryonal carcinoma stem cells to determine if neuropathic OP, mipafox, and  
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non-neuropathic OP, paraoxon, are able to alter differentiation of neural precursor cells  
in vitro. Exposure to 1 µM paraoxon (non-cytotoxic concentrations) altered the expression 
of different genes involved in signaling pathways related to chromatin assembly and 
nucleosome integrity. Conversely, exposure to 5 µM mipafox, a known inhibitor of NTE 
activity, showed no significant changes on gene expression. We conclude that 1 µM 
paraoxon could affect the initial stage of in vitro neurodifferentiation possibly due to a 
teratogenic effect, while the absence of transcriptional alterations by mipafox exposure  
did not allow us to conclude a possible effect on neurodifferentiation pathways at the  
tested concentration.  
Keywords: neurodifferentiation; neurodevelopmental toxicity; NT2; organophosphorus 
pesticides; NTE; human embryonal carcinoma stem cells 
 
Abbreviations and organophosphorus compounds common names: AChE = Acetylcholinesterase; 
DAPI = 4-6-diamidino-2-phenylindole; FBS = foetal bovine serum; FGFR1 = Fibroblasts growth 
factor receptor 1; GFAP = Glial fibrillary acidic protein; NT2 = human-derived NTera2/D1 cells; 
MAP2 = Microtubule-associated protein 2; Mipafox = N,N-diisopropyl diamidophosphorofluoridate; 
MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NCBI = National Center for 
Biotechnology Information; NTE = neuropathy target esterase; OPs = organophosphorus compounds; 
Paraoxon = O,O'-diethyl p-nitrophenyl phosphate; PBS = phosphate buffered saline; PV = phenyl 
valerate; RA = retinoic acid; SEM = standard error of the mean; YAP1 = Yes-associated protein 1. 
1. Introduction 
Organophosphorus compounds (OPs) have been used worldwide as pesticides for insect control.  
In Europe alone, OP insecticide production was close to 31,000 tons in 2010 [1]. The American 
Association of Poison Control Centers reported almost 4000 exposures to OPs and four  
exposure-related fatalities in 2010 [2]. Many OPs target the nervous system of insect pests. Because of 
the similarity of neurochemical processes, these compounds are also likely to be neurotoxic to human 
brain, especially to the developing nervous system which is inherently much more vulnerable to injury 
caused by toxic agents than the brain of adults [3–5]. Indeed, there are evidences that pesticides reduce 
motor activity, latency and cause visuospatial deficits after high exposure [6,7]. The main mechanism 
of action of OPs is based on irreversible enzyme inactivation caused by the phosphorylation of the 
active centre of esterases located in the neurons of the central and peripheral nervous systems [8].  
The inhibition of esterases can cause two main types of poisoning effects. The insecticidal effects of 
OPs are specifically due to acetylcholinesterase (AChE) inhibition, which is essential for the 
transmission of nervous signals in target (insects) and non-target (e.g., humans and other mammals) 
species [8]. However, another syndrome has been described after exposure to some OPs, the so-called 
organophosphorus-induced delayed polyneuropathy. This is a paralyzing syndrome characterized by 
the degeneration of nerve axons, which is clinically detectable 14 to 16 days post-exposure [9]. 
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Conversely, this delayed neuropathy is triggered by the phosphorylation and further chemical 
modification of an esterase (other than AChE) called Neuropathy Target Esterase (NTE) [9]. 
In addition, low-level chronic exposures, which usually take place in occupational environments, 
can cause other neurotoxic effects. Incidences of neurological and neurodegenerative diseases have 
been reported in epidemiologic studies performed with pesticide spreaders, greenhouse workers, 
agricultural workers and farmers occupationally exposed to pesticides (including OPs) [10–12].  
OPs also might be developmental toxicants due to the inhibition of esterases during pregnancy, 
oxidative stress or endocrine disruption [13]. It has also been suggested that the neurodevelopmental 
toxicity of OPs may be due to direct interference with the morphogenic activity that AChE normally 
displays during neurodevelopment [14,15], which might alter neural connectivity, induce long-lasting 
changes in spatial learning and memory formation [16], or alter the expression of genes involved in 
nervous system development [17,18], as it is specifically described for the OP chlorpyrifos. 
Epidemiologic and laboratory animal studies suggest that pesticides (OPs, carbamates, pyrethroids and 
others) can cause developmental neurotoxicity [3]. In addition, an anthropological study of children 
aged 4–5 years in Mexico showed that children highly-exposed to pesticides demonstrated decreases in 
stamina, gross and fine eye-hand coordination, perturbation in short term memory, and the ability to 
draw a picture of a person [19].  
Neurotoxic effects depend on the developmental window in which the exposure takes place and can 
be particularly severe in early stages, when complex cellular-molecular processes of neural progenitor 
cell commitment, cell proliferation, migration and differentiation take place [4,5,20]. Damage to any of 
these processes can cause a variety of adverse health effects, such as mental retardation, altered 
behavior and other neurodevelopmental diseases [21]. 
Human-derived NTera2/D1 (NT2) cells have the capacity to differentiate into fully mature neuronal 
and astrocyte-like cells [22]. During this process, the neuron-like cells derived from NT2 neural 
progenitor cells could serve as a valuable model for developmental neurotoxicity studies since various 
cell differentiation stages can be followed in these cultures [23,24]. 
The main goal of this study is to determine whether exposure to model OPs during retinoic acid 
(RA)-induced differentiation of pluripotent cells is able to affect the neural commitment of progenitor 
cells followed by the alterations in the initial process of neuronal differentiation. Indeed, this very 
early exposure of neural progenitor cells to environmental toxicants seems to be one of the most 
sensitive time intervals during development causing neurotoxicity [25,26]. Microarray technology has 
been used to screen the developmental neurotoxic effects induced by OPs [27]. We studied alterations 
in the expression of the whole human genome in RA-induced differentiation of pluripotent cells towards 
neural progenitors from NT2 cells by exposure to non-neuropathic OP paraoxon (the physiologically 
active derivative of the insecticide parathion) or neuropathic OP mipafox. Non-cytotoxic 
concentrations of paraoxon affected the expression of several genes related mainly to DNA and 
nucleosome integrity. In contrast, mipafox exposure showed no changes in gene expression.  
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2. Results 
2.1. Cell Viability after Exposure to OPs 
In the dose response assessment of paraoxon and mipafox, NT2 cells were exposed for 4, 10 and  
15 days to several paraoxon and mipafox concentrations ranging between 0.5 and 300 µM. After  
4 days exposure to paraoxon, only concentrations higher than 200 µM reduced cell viability (p < 0.05)  
(Figure 1), while none of the tested mipafox concentrations had any effect as evaluated by MTT assay. 
However, after 10 days of mipafox exposure to the concentrations higher than 70 µM, the cells showed 
significant loss in cell viability (Figure 1). After longer time of exposure, 15 days, paraoxon and 
mipafox significantly reduced cell viability (p < 0.05) at concentrations higher than 100 µM and  
200 µM respectively, while 1 µM paraoxon and 5 µM mipafox did not alter viability (Figure 2).  
Based on these results, 1 µM paraoxon and 5 µM mipafox were selected for transcriptomics studies as  
non-cytotoxic concentrations. 
2.2. Effect of Paraoxon and Mipafox on NTE Activity  
Non-neuropathic OP paraoxon did not inhibit NTE after 4, 10 or 15 days of exposure (Figure 3). 
Conversely, neuropathic OP mipafox caused an extensive inhibition of NTE (Figure 3). This inhibition 
was significant after 4 days of exposure to 5 µM mipafox, and reached approximately 8% of control 
activity after exposure to 300 µM (Figure 3). Similar results were observed after 10 and 15 days  
of exposure.  
Figure 1. NT2 neural progenitor cells. (A) Phase contrast images showing NT2 neural 
progenitor cells; (B) Expression of NPC (neural progenitor cells) marker, nestin, co-stained 
with 4',6-diamidino-2-phenylindole (DAPI) show 100% positive nestin cells. Bars 
correspond to 500 µm.  
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Figure 2. Effect of paraoxon and mipafox on cell viability of NT2 cells during the first 
stage of neurodifferentiation measured by MTT assay. Cells were exposed to 0.5, 1, 5, 10, 
25, 40, 70, 100, 150, 200 and 300 µM of either paraoxon (●) or mipafox (▲) for 4 days 
(A); 10 days (B); and 15 days (C). Data represent mean ± SEM of the four independent 
experiments with 16 independent technical replicates for each experimental condition run. 
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Figure 3. Changes in NTE activity of the NT2 cells exposed to paraoxon or mipafox 
during the neurodifferentiation process. Cells were exposed to 0.5, 1, 5, 10, 25, 40, 70, 100, 
150, 200 and 300 µM of either paraoxon (●) or mipafox (▲) for 4 days (A); 10 days (B); 
and 15 days (C). NTE activity is expressed as the percentage of activity determined in the 
time-matched control (non-exposed) cultures. Data represent mean ± SEM of three 
independent experiments with 8 technical replicates for each experimental condition.  
(* statistically different from the controls for p < 0.05 with a Dunnett’s test).  
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2.3. Microarray Analysis after 4-Day Exposure  
The mRNA expression across the whole human genome was evaluated in NT2 cells during the 
initial stage of RA-induced differentiation of pluripotent cells towards the neural committed progenitor 
cells after 4 days of exposure to 1 µM paraoxon or 5 µM mipafox (both are non-cytotoxic 
concentrations) using microarray analysis. Paraoxon caused a statistically significant alteration in the 
expression of 137 genes, while exposure to mipafox altered the expression of a single gene (Figure 4). 
No overlapping was noted between the genes altered by paraoxon exposure and the single gene altered 
by mipafox exposure (Figure 4). The one gene modified by mipafox treatment was a long non-coding 
RNA, a non-protein coding transcript related with a transcription function. 
Figure 4. Venn diagram of the genes with altered expressions after exposure to paraoxon 
and mipafox. Cells were exposed to 1 µM paraoxon or 5 µM mipafox for 4 days. 
Afterwards, the whole human genome expression was recorded using microarrays, as 
described in Section 4.6. Each compartment represents the number of genes with a 
statistically (at least corrected p < 0.05) altered expression found in each condition.  
↓ down-regulated genes, ↑ up-regulated genes. 
 
The data obtained from gene expression studies was further analyzed with the DAVID software 
using the Gene Ontology database separated into three parts: biological process, molecular function 
and cellular components [28]. For analysis purposes, only those genes with a fold change higher than 2 
or lower than 0.5 and with a corrected p-value lower than 0.05 were considered. The highest 
enrichment score was found for a cluster of genes related to nucleosome and chromatin assembly 
(Table 1). An independent analysis of the up-regulated and down-regulated genes showed that these 
modifications were attributable to down-regulated genes (raw data in Supplementary Materials 2). 
Table 2 shows the genes which mRNA levels altered up-regulated and down-regulated after paraoxon 
exposure. The function of most of these genes is related to chromatin assembly and chromatin 
regulation (HIST1H2AB, HIST1H4E, CBX3), apoptosis (FKSG2 and UBE2Z) or cell–cell signaling 
and differentiation (FGFR1, YAP1, SRGAP2P2).  
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Table 1. Gene set enrichment analysis. Cells were exposed to 1 µM paraoxon for 4 days in 
RA-induced differentiation medium. All genes with statistically (p < 0.05) altered expressions 
and a fold change higher than 2 or lower than 0.5 were uploaded for further analysis  
in the DAVID bioinformatics (Nature. Available online: http://www.nature.com/nprot/ 
journal/v4/n1/abs/nprot.2008.211.html (accessed on 26 December 2013). * p-value < 0.05. 
Function 
Number of genes associated 
with processes altered 
Corrected 
p-value 
Cluster Enrichment score = 1.7 
Chromatin assembly  4 0.001 * 
Nucleosome assembly 3 0.010 * 
Protein-DNA complex assembly 3 0.011 * 
Nucleosome organization 3 0.012 * 
Cellular macromolecular complex assembly 4 0.018 * 
DNA package 3 0.018 * 
Cellular macromolecular complex subunit organization 4 0.024 * 
Chromatin organization 4 0.028 * 
Chromosome organization 4 0.053 * 
Cluster Enrichment score = 1.33 
Enzyme binding 6 0.0019 * 
Cell death 5 0.036 * 
Death 5 0.037 * 
Apoptosis 3 0.29 
Programmed cell death 3 0.3 
Cluster Enrichment score = 1.04 
Regulation of cell size 3 0.051 * 
Regulation of cellular component size 3 0.083 
Neuro differentiation 3 0.18 
2.4. Effect of Paraoxon and Mipafox on the Morphology of NT2-Derived Neurons 
The morphology of NT2 cells differentiating towards neuronal-like phenotype for 13 days (in the 
presence of RA) were stained positively against β-Tubulin III (neuronal specific marker) and their 
morphology was analyzed using the imaging platform Cellomics ArrayScan vTi (Thermo Scientific 
Cellomics®, Pittsburgh, PA, USA), as described in Section 4.6. Paraoxon caused a statistically 
significant increase (11.4% regarding the control, p < 0.05) in the total number of differentiated 
neuronal-like cells (cell bodies with more than 3 processes or with processes whose total length was 
longer than 6.5 µm) present in cultures, while no differences in this parameter were recorded between 
the control and mipafox-exposed cultures (Figure 5A). Likewise, the total number of branch points in 
differentiating cells was higher (258% of control, p < 0.05) in the cultures that were differentiating in 
the presence of paraoxon than in the control cultures, while the presence of mipafox did not alter the 
number of branch points (Figure 5B). However, the cultures exposed to both paraoxon or mipafox 
displayed no significant differences in terms of total length of neurites per well (Figure 5C) and total 
number of dense (non-apoptotic) nuclei per well (data not shown). 
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Table 2. Genes altered in NT2 cells induced by paraoxon during the initial stage of  
RA-induced differentiation of pluripotent cells towards the neural committed progenitor 
cells. Cells were exposed to 1 µM paraoxon for 4 days in RA-induced differentiation.  
Data represent the genes linked to altered mRNA levels compared to control (non-exposed) 
cultures as identified according to the National Center for Biotechnology Information 
(NCBI) database. 
Gene Name NCBI entry FC real 
HIST1H4E histone cluster 1, H4e 8367 −1.69 
LUZP6 leucine zipper protein 6 767558 −1.57 
LOC400804 hypothetical LOC400804 400804 −1.24 
HIST1H2AB histone cluster 1, H2ab 8335 −1.23 
C14orf162 chromosome 14 open reading frame 162 56936 −1.19 
YAP1 Yes-associated protein 1 10413 −1.15 
FGFR1 fibroblast growth factor receptor 1 2260 −1.05 
AKAP12 A kinase (PRKA) anchor protein 12 9590 −1.03 
UBE2Z ubiquitin-conjugating enzyme E2Z 65264 −1.01 
SRGAP2P2 SLIT-ROBO Rho GTPase activating protein 2 pseudogene 2 647135 −1.01 
AXIN2 axin 2 8313 −1.00 
LOC646214 p21-activated kinase 2 pseudogene 646214 1.00 
LOC100130654 hypothetical protein LOC100130654 100130654 1.00 
CCR6 chemokine (C-C motif) receptor 6 1235 1.01 
C14orf135 chromosome 14 open reading frame 135 64430 1.01 
KIRREL2 kin of IRRE like 2 (Drosophila) 84063 1.01 
C2orf27A chromosome 2 open reading frame 27A 29798 1.02 
BMP8B bone morphogenetic protein 8b 656 1.03 
RNF113B ring finger protein 113B 140432 1.05 
GCLM glutamate-cysteine ligase, modifier subunit 2730 1.06 
TTC16 tetratricopeptide repeat domain 16 158248 1.07 
PARP4 poly (ADP-ribose) polymerase family, member 4 143 1.07 
LOC100134868 hypothetical LOC100134868 100134868 1.07 
SCD5 stearoyl-CoA desaturase 5 79966 1.08 
PTK2B PTK2B protein tyrosine kinase 2 beta 2185 1.08 
LAT2 linker for activation of T cells family, member 2 7462 1.10 
RPL13AP17 ribosomal protein L13a pseudogene 17 399670 1.10 
ACBD5 acyl-CoA binding domain containing 5 91452 1.16 
C1orf152 profilin 1 pseudogene 767846 1.17 
YY2 YY2 transcription factor 404281 1.18 
LOC100133791 hypothetical protein LOC100133791 100133791 1.21 
LOC100233209 hypothetical LOC100233209 100233209 1.24 
ILDR1 immunoglobulin-like domain containing receptor 1 286676 1.26 
LOC648740 actin, beta pseudogene 648740 1.28 
SET SET nuclear oncogene 6418 1.29 
LOC100131581 hypothetical LOC100131581 100131581 1.29 
CXCL5 chemokine (C-X-C motif) ligand 5 6374 1.30 
NACAP1 
nascent-polypeptide-associated complex alpha polypeptide 
pseudogene 1 83955 1.30 
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Table 2. Cont. 
Gene Name NCBI entry FC real 
KRTAP10-9 keratin associated protein 10-9 386676 1.33 
CBX3 chromobox homolog 3 11335 1.37 
SNRPD2P2 small nuclear ribonucleoprotein D2 pseudogene 2 645339 1.39 
SGSM2 small G protein signaling modulator 2 9905 1.42 
ANXA2 annexin A2 302 1.59 
REREP3 arginine-glutamic acid dipeptide (RE) repeats pseudogene 3 646396 1.78 
FKSG2 tumor protein, translationally-controlled 1 pseudogene 59347 1.80 
TXNDC17 thioredoxin domain containing 17 84817 1.94 
Figure 5. Effects of paraoxon and mipafox on the neural differentiation. During the initial 
process of neural differentiation NT2 cells were seeded on 96-well plates and exposed to  
1 µM paraoxon or 5 µM mipafox for 13 days. Using the Cellomics ArrayScan device the 
following morphological parameters of the cells positively stained against β-Tubulin III 
were quantified: differentiating neuronal-like cells (cells with more than 3 neurites or with 
a neurite total length longer than 6.5 µm) (A); number of branch points (B) and length of 
neurites (C); Each Figure shows the results obtained together with a representative picture, 
randomly selected among those employed for quantification. Each experimental condition 
was assayed in 16 wells (6 different pictures per well). Plots represent mean ± SEM of  
all records performed per each experimental condition. * statistically different from the 
controls for p < 0.05 with Dunnett’s test. Pictures show morphology and staining of 
analyzed cultures (white bars represent 500 µm); (D) Nuclear staining with DAPI;  
(E) Staining of neuronal bodies with â-tubulin III; (F) Double staining (green for β-tubulin 
III and blue for DAPI); and (G) The same picture analyzed Cellomics ArrayScan device. 
Note in (G) blue cellular outlines for neurons with neurites meeting the above defined 
threshold, while red outlines remark neuronal bodies that were not quantified because they 
did not meet the set threshold. See also in (G) neurites (green) and nuclei (blue) that were 
not outlined for quantification because they were not considered as neurons.  
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Figure 5. Cont. 
 
3. Discussion  
The main mechanism for acute toxic effects of OPs is the inhibition of AChE in the nervous system. 
Nevertheless, other deleterious effects have been reported for these pesticides, such as inhibition of 
other esterases (i.e., NTE), damage to DNA and RNA synthesis [29], dysregulation of signal transduction 
pathways [30], oxidative stress [30], astroglial proliferation [31], embryogenesis dysfunction [32,33].  
In this work, we used a neuronal progenitor cells of undifferentiated NT2 cells in the presence of 
RA, to study the effects of mipafox (a neuropathic OP capable of inhibiting NTE and inducer of the 
so-called organophosphorus induced polyneuropathy) [34] and paraoxon (a non-neuropathic OP that is 
not able to inhibit NTE) [35,36] on the initial stages of neuronal differentiation process under in vitro 
conditions. This early exposure of neural progenitor cells to environmental chemicals seems to be one 
of the most sensitive time intervals of exposure in the context of developmental neurotoxicity. Indeed, 
it has been shown that NT2 derived neural precursors were already affected by non-cytotoxic 
concentrations of methyl mercury [25,37]. In contrast these concentrations did not affect the markers 
of more mature cells, indicating that the early window of exposure is more sensitive than later stages 
of neuronal differentiation. A similar conclusion was obtained based on the exposure of a human 
neural precursor cells derived from umbilical cord blood (HUCB-NSC) to various developmental 
neurotoxic compounds, including methyl mercury chloride. Less differentiated cells of HUCB-NSC 
were more sensitive to neurotoxicants [25] than the cells at the later stage of neuronal differentiation. 
Compounds that can affect the very initial stage of neural precursor’s commitment are potential 
developmental neurotoxicants and this early exposure can be critical for changes observed in the 
neuronal/glial ratio and/or neuronal/glial cell morphology and function. NT2 are capable to 
differentiate in both neuronal and glial cells. 
In this study mRNA levels have been found to be modified based on microarray analysis of the cells 
exposed to paraoxon during 4 days. Preliminary studies have shown that after 13 days of exposure to 
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paraoxon, the cells differentiating towards neuronal phenotype (stained positively against β-Tubulin III) 
have a tendency towards increased number of branch points and higher number of differentiated 
neuronal-like cells (Figure 5). However, further studies are needed to confirm this. The results obtained 
from mRNA expression modification point towards the fact that paraoxon could have an effect on early 
stages of neural precursor commitment and the initial differentiation into neuronal-like cells.  
3.1. Effects of Mipafox during NT2 Neurodifferentiation 
Previous studies with mipafox have reported that different NTE inhibiting neuropathic OPs caused 
reduced neurites length in the SH-SY5Y human neuroblastoma [38], N2a mouse neuroblastoma [39], 
C6 rat glioma [40], sympathetic neurons deriving from superior cervical ganglia [41], chick embryo 
dorsal root ganglia [42] or PC12 cells [43]. Moreover, Henschler et al. [44] reported that 26 different 
neuropathic OPs reduced the length of the neurites-like processes induced by dibutyryl cAMP in the 
N18 mouse brain neuroblastoma and processes of the C6 rat brain glioma cells while eight  
non-neuropathic OPs did not. However, the studies in which EB2.2 mouse embryonic stem cells with 
the knocked-out NTE encoding gene were used; a delay in the onset of neurite outgrowth  
(but no effect on their total length) was observed [45]. The above-reported differences can be 
explained on the basis of different cellular models, different concentrations applied, time of exposure 
and on mechanisms of reduction of NTE activity (chemical inhibition of the protein with mipafox or 
other neuopathic OPs in SH-SY5Y, C6, PC12, N18 cells and chick embryo dorsal root ganglia or 
genetic silencing in EB2.2 cells and D3 mouse embryonic stem cells). NT2 is a human embryonal 
carcinoma cell line classified as stem cells that can differentiate into post-mitotic neurons under  
RA exposure [22], while the other cellular systems used for studying alterations in neurites outgrowth 
are either somatic stem cells or adult cells. Therefore, it can be expected that these cells were at 
different stages of differentiation processes during mipafox exposure, which might determine the 
response of differentiating cells to the insult of the OP.  
In our studies no genetic modifications due to mipafox exposure have been reported. However, 
interference RNA for Pnpla6 (NTE encoding gene) has shown different genetic modifications in  
D3 mouse embryonic stem cells during the differentiation of embryonic bodies [32]. A reduction of 
NTE enzymatic activity in NT2 cells did not produce any modifications in gene expression. Again, 
these differences could be due to the different cellular models used, different concentrations applied 
and time of exposure as well as different mechanisms of reduction of NTE activity (genetic repression 
of Pnpla6 or NTE enzymatic activity inhibition).  
3.2. Effects of Paraoxon during Initial Stage of NT2 Neurodifferentiation 
Parathion and, in consequence, the physiologically active derivative paraoxon have shown to induce 
developmental neurotoxicity effects in humans [46]. Paraoxon exposure caused changes in mRNA 
levels as determined by microarray analysis already after 4 days of neuronal differentiation triggered 
by RA. These findings may support our preliminary results where increased neuronal differentiation 
(number of total differentiating cells towards neuronal phenotype and number of branch points  
(Figure 5) after exposure to paraoxon was observed. Such effect could change the networking between 
the mature neurons that can be obtained in this cell model. Indeed, based on our early studies [47] 
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these cells have capacity to differentiate into fully mature neurons following the protocol described  
by Pleasure [48]. 
The pathway analysis performed with the DAVID bioinformatics tool for the 137 genes with altered 
expression strongly suggests an association with the pathways related to DNA integrity and to 
nucleosome and chromatin assembly (Table 1). The analysis of the altered mRNA levels of different 
genes (Table 2) reveals that they belong to different families, such as CBX3, related to chromatin 
regulation [49], or HIST1H4E and HIST1H2AB, related with nucleosome assembly [50], or YAP1, 
related with the regulation of different processes in development [51]. These results are consistent with 
other reports where DNA damage in the lymphocytes of workers occupationally exposed to OPs was 
detected [52–54]. 
The exposure to paraoxon down-regulates also the mRNA levels of growth factor receptor 1 
(FGFR1) that is involved in cellular proliferation. It was demonstrated, for example, that FGFR1-deficient 
mice develop an abnormal olfactory bulb due to failure in the decrease of cell proliferation, indicating 
that FGF signaling is required to inhibit proliferation at the anterior tip of the forebrain [55].  
Yes-associated protein 1 (YAP1) is a transcriptional co-activator that controls cell proliferation and 
differentiation in a variety of tissues during development. An increase in differentiation in mouse 
retina cells after silencing has been demonstrated [56]. Both mRNA levels of (FGFR1 and YAP1) 
were down-regulated after 4 days of exposure to paraoxon (Table 2), which could support the increase 
in the number of differentiated neurons found 13 days after neurodifferentiation (Figure 5). 
Additionally, mRNA levels of other genes such as FGFR1, SGSM2, SET, SCD5 related to nervous 
system development have been modified. However, paraoxon and paraoxon-methyl have been also 
shown to produce teratogenicity and genotoxicity in different models [57–59]. Moreover, gene set 
enrichment analysis has shown mRNA levels modify of genes related with apoptosis and cell size 
regulation (Table 1) function. Taking these results into consideration, it is possible that the effects 
observed in our study may be due to teratogenicity induced by paraoxon. Indeed, microarrays analysis 
have shown impaired chromosome packaging and organization (Table 1) that could produce 
chromosome aberration, normally linked with teratogenicity effects.  
4. Material and Methods 
4.1. Chemicals 
Paraoxon (O,O'-diethyl p-nitrophenyl phosphate) was obtained from Sigma-Aldrich S.A.  
(Madrid, Spain) and mipafox (N,N-diisopropyl diamidophosphorofluoridate) was purchased from Lark 
Enterprise (Webster, MA, USA).  
4.2. NT2 Cell Differentiation into Neuronal-like Cells 
The NTERA-2 cl. D1 (NT2) cell line derived from human teratocarcinoma, was purchased from  
the American Type Culture Collection (Rockville, MD, USA). Two different culture media (for 
proliferation of neural progenitor cells (NPC) and for neuronal differentiation) were used according to 
the protocol described by Pleasure et al. [48]. Initially, the neural progenitor NT2 cells (Figure 1) were 
cultured in uncoated 75-cm2 flasks (Nunc, New York, NY, USA) at a density of 4 × 104 cells/cm2 and 
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maintained in Opti-MEM (Gibco) media supplemented with 5% heat-inactivated FBS (HyClone, 
Logan, UT, USA), plus 50 U penicillin/mL and 100 µg/mL streptomycin (Gibco, Carlsbad, CA, USA). 
In order to induce neural differentiation, cells were trypsinized and cultured in DMEM-HG (Gibco) 
medium supplemented with 10 µM retinoic acid (RA; Sigma, St. Louis, MO, USA), 10% FBS 
(HyClone, Logan, UT, USA ), 50 U penicillin/mL and 100 µg/mL streptomycin. During the RA-induced 
differentiation process, the NT2 cells were seeded in different plate formats (see following sections), 
depending on the experimental aim, and exposed to OPs (paraoxon and mipafox). OPs were freshly 
dissolved in cell culture media which was replaced every 2 days. 
4.3. Assessment of Cell Viability Using the MTT Assay  
To select the non-cytotoxic concentrations of paraoxon an mipafox MTT assay was performed that 
is widely used for evaluation of the in vitro cell viability in toxicity studies [20,28]. 
Cells were seeded at a density of 25 × 103 cells/cm2 in uncoated 96-well plates (BD, Franklin 
Lakes, NJ, USA) and cultured in RA-induced differentiation media being simultaneously exposed to 
different paraoxon and mipafox concentrations ranging between 0 and 300 µM (0, 0.5, 1, 5, 10, 25, 40, 
70, 100, 150, 200 and 300 µM) for 4, 10 and 15 days starting treatment on day 0 of differentiation. 
Cell culture medium was changed every 2 days. Cells were washed twice with phosphate buffered 
saline (PBS) (137 mM NaCl; 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4) and 200 µL of  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (1 mg/mL) were added 
to each well. After 3 h the cells were washed with PBS and 100 µL of dimethyl sulfoxide were added 
to each well. Plates were submitted to shaking (50 rpm, 10 min) to ensure a complete dissolution of 
formazan crystals. Finally, absorbance was read at 540 nm in a microplate reader (Infinite® 200 PRO 
series, Tecan Group Ltd., Männedorf, Switzerland) and the percentage of cell viability after exposure 
was calculated by assuming 100% of viability for the absorbance recorded in the control (non-exposed) 
cultures. Four independent experiments per time point were performed in each of which  
sixteen independent technical replicates (independent wells) were used to test each experimental  
condition (Figure 2). 
4.4. NTE Enzymatic Activity 
NTE activity was determined by the method of Pamies et al. [30] that is defined as phenyl valerate 
(PV) esterase (PVase) activity resistant to paraoxon and sensitive to mipafox. B (paraoxon-resistant) 
and C activity (resistant to both paraoxon and mipafox) are discriminated by the result from the 
differential sensitivities of NT2 PV esterases to nonneurotoxic paraoxon and to neurotoxic mipafox [36]. 
Briefly, B activity was defined and recorded as the PV hydrolyzing activity in those samples 
preincubated for 30 min at 37 °C with 40 µM paraoxon. C activity was defined and recorded as  
PV hydrolysing activity in the samples preincubated with 40 µM paraoxon plus 250 µM mipafox.  
In this method, NTE activity is calculated as B-C. Three independent experiments were performed in 
which 8 independent technical replicates were done to test each experimental condition (B and C 
activity measurements) at three time points (4, 10 and 15 days).  
Cells cultured under RA-induced neurodifferentiation were seeded at density of 2 × 105 cells/cm2 in 
96-well uncoated plates. These cells were exposed during 4, 10 and 15 days to OPs at the 
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concentrations ranging between 0 and 300 µM (0, 0.5, 1, 5, 10, 25, 40, 70, 100, 150, 200 and 300 µM), 
starting the exposure at day 0 of differentiation. On each measurement day, cells were washed with 
PBS and incubated with 40 µM paraoxon alone or in combination with 250 µM mipafox in PBS for  
30 min at 37 °C to record B and C activities. The medium containing paraoxon or mipafox was removed 
and 100 µL of 7.5 mM PV in PBS were added to each well and incubated at 37 °C for 60 min. The 
reaction was stopped by adding 100 µL of 2% SDS-0.25 mg 4-aminoantipyrine/mL in 50 mM TRIS-1 
mM EDTA buffer (pH 8.0). After 15 min at room temperature, 50 µL of 1% (w/v) potassium 
ferricyanide (in water) were added. The released phenol was quantified by recording absorbance at 510 
nm and by comparing to the standard curve of the phenol. NTE enzymatic activity (B-C) across three 
independent experiments was determined and plotted against time (Figure 3). In addition, NTE 
enzymatic activity was measured in parallel to microarray analysis experiments (Figure S1). 
4.5. Microarray Studies 
Maximum inhibition of NTE appeared 2 days after exposure to mipafox (Figure S1). For this 
reason, four days exposure to paraoxon and mipafox during RA-induced differentiation were chosen 
for the microarray study as this allowed two additional days for any alterations caused by NTE 
inhibition to translate to all complex genetic pathways. The concentrations tested were based on the 
following rational; 1 µM paraoxon is high enough to inhibit AChE and other esterases not related with 
NTE after chronic exposures such as those employed in this study, because these enzymes are usually 
inhibited after 30 min exposure to paraoxon concentrations ranging between the nM and µM  
units [35,60–62]. Similarly, 5 µM mipafox is able to cause significant inhibition of NTE, as we 
confirmed in experiments described in Section 4.4. It has been shown that this concentration also 
inhibits AChE since the ratio between IC50 for inhibition of AChE and NTE by mipafox ranges 
between 1 and 10 [60].  
For microarray studies the cells were cultured in petri dishes (60 mm, at the initial cellular density 
of 5 × 104 cells/cm2) under RA-induced differentiation conditions (as described in Section 4.2.) for  
4 days in the presence of 1 µM paraoxon, or 5 µM mipafox. After 4 days of the exposure to OPs RNA 
was isolated from treated cells and the control culture (non-treated). In parallel with microarray gene 
expression studies, the NTE enzymatic activity experiment was performed (Figure S1).  
The RNeasy Plus kit (Qiagen, Germantown, MD, USA) was used. Total RNA was quantified using 
a ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and its 
integrity was assessed with the Agilent 2100 Bioanalyzer (Agilent, Milano, Italy) according to the 
manufacturer’s instructions. All the RNA samples used in this study met the criteria of 260/280 ratio 
above 1.9 and an RNA Integrity number above 9.0. The microarray experiment was designed to 
perform three technical replicates for each treatment and all the samples were isolated and process at 
the same time. Sample-labelling, hybridization, washing and scanning steps were conducted following 
the manufacturer’s specifications. In short, Cy3-labelled cDNA was generated from 500 ng of input 
total RNA using the Quick Amp Labeling Kit, One-color (Agilent). For each sample, 1.65 µg of 
cDNA from each labelling reaction (with a specific activity above 9.0) was hybridized using the Gene 
expression Hybridization Kit (Agilent) to the Agilent Whole Human Genome Oligo Microarray 
(Agilent), which is a 4 × 44 k 60 mer slide format where all 4 arrays represent about 41,000 unique 
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genes and transcripts. After hybridization, slides were washed and then scanned in the Agilent 
G2565BA Microarray Scanner. The fluorescence intensities on the scanned images were extracted and 
pre-processed by the Agilent Feature Extraction Software (version 10.5.1.1, Agilent, Milan, Italy). 
Quality control and array normalization were performed in the R statistical environment using the 
Agi4 × 44PreProcess package downloaded from the Bioconductor web site. The normalization and 
filtering steps were based on those described in the Agi4 × 44PreProcess reference manual. In order to 
detect expression differences among different cell populations, a moderated t test was applied. 
Moderated t statistics were generated by the Limma Bioconductor package. Differentially expressed 
genes were defined as those with a log (base 2) fold change higher than 1 or lower than −1, and a false 
discovery rate (Benjamini and Hochberg’s method) corrected by p-value smaller than 0.05 [63].  
All the above computations were conducted using the R statistics programming environment.  
The expression microarray data have been deposited in the NCBI Gene Expression Omnibus and 
are accessible through GEO series accession number GSE38050 (NCBI. Available online: 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38050 (accessed on 26 December 2013)). 
The microarray results were analyzed by the DAVID (Nature. Available online: 
http://www.nature.com/nprot/journal/v4/n1/abs/nprot.2008.211.html, accessed on 26 December 2013) 
database. The analysis identified the biological functions that were altered by exposure to OPs.  
A right-tailed Fisher’s exact test was used to calculate a p-value to determine the probability that each 
biological function assigned to that data set is due to chance alone. 
4.6. Evaluation of Cell Morphology Using Fluorescence Imaging  
RA-induced cell differentiation was performed at density of 4160 cells/cm2 in 96-well uncoated 
plates. The cells were exposed for 13 days to either 1 µM paraoxon or 5 µM mipafox beginning at day 
1 of differentiation. This time-point (13 days of neurodifferentiation) was chosen as it was considered 
to be optimal to study cell morphology (based on our own observations). Longer times of 
neurodifferentiation were not considered appropriate because cell processes were too dense and 
compromised quantification (data not shown). Cells were washed with PBS buffer and fixed for  
15 min at room temperature with 4% paraformaldehyde and then permeabilized for 10 min at room 
temperature (RT) with 0.1% Triton X-100 in PBS. Cells were incubated for 30 min at RT (room 
temperature) with blocking buffer (3% FBS in PBS) on a shaker and further incubated overnight at  
4 °C with β-Tubulin III (neuron-specific marker) primary antibody (Sigma T8578) diluted 1:200 in 
blocking buffer. Then, cells were gently washed three times with fresh medium and incubated (1 h at 
RT in the dark and with horizontal shaking) with fluorophore conjugated with the secondary antibody 
Alexa 546 (Invitrogen A21123) diluted 1:500 in blocking buffer. At the end of the process cells were 
incubated for 10 min at RT with 4-6-diamidino-2-phenylindole (DAPI) diluted at 1:5000 in PBS for 
staining the cell nuclei. DAPI was used for nucleus staining (a fluorescent stain that binds strongly to 
A-T rich regions in DNA). Cell morphology was analyzed using the imaging platform Cellomics 
ArrayScan vTi (Thermo Scientific Cellomics®, Pittsburgh, PA, USA). The software (Neuronal 
Profiling version 4, BioApplication from Cellomics Scan Software (Thermo Scientific Cellomics®, 
Pittsburgh, PA, USA)) was set to measure number of branch points, neurite length and percentage of 
differentiated neurons per total neuron count. The threshold for considering cells as differentiated 
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neurons was more than 3 neurites or a neurite of a total length longer than 6.5 µm associated to a 
single cell body. 
5. Conclusions 
The obtained results suggest that the NT2 cell line is a suitable in vitro model for studying the effect 
of OPs on the initial stages of RA-induced differentiation of pluripotent stem cells towards neural 
committed progenitor cells followed up by the early processes of neuronal-like cell differentiation.  
Paraoxon and mipafox have been used as examples to study non-neuropathic and neuropathic OPs, 
respectively. Paraoxon alters the initial in vitro differentiation process of neural progenitor cells, 
probably due to chromosome packaging and chromatin organization. Further studies are needed to 
clarify whether these effects might cause some of the neurodevelopmental toxic effects attributed to 
OPs. Nevertheless, we previously estimated that in vivo paraoxon exposures causing severe 
cholinesterase syndrome would yield systemic concentrations of 0.1–0.3 µM [64]. Therefore, 1 µM, 
the concentration at which the in vitro effects reported in this work were observed, would be 
comparable with clinical cholinergic symptoms. Thus, low risk during developmental stages is 
expected, which is consistent with data showing alteration in the gene expression profile of D3 mouse 
embryonic stem cells exposed to chlorpyrifos at concentrations which also cause moderate AChE 
inhibition [17]. On the other hand, 5 µM of mipafox was able to reduce NTE enzymatic activity.  
No modifications were observed in mRNA levels, indicating that NTE enzymatic activity is probably 
not involved in genetic signaling. Our insights into the effects of paraoxon exposure during early 
windows of cell differentiation call for more data to complete risk characterization since we have 
studied a single concentration (1 µM) and further concentrations would provide information on where 
the threshold for the described effects lies. 
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